Radiation Therapy in Hematologic Malignancies (eBook, PDF)
An Illustrated Practical Guide
Redaktion: Dabaja, Bouthaina Shbib; Ng, Andrea K.
72,95 €
72,95 €
inkl. MwSt.
Sofort per Download lieferbar
36 °P sammeln
72,95 €
Als Download kaufen
72,95 €
inkl. MwSt.
Sofort per Download lieferbar
36 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
72,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
36 °P sammeln
Radiation Therapy in Hematologic Malignancies (eBook, PDF)
An Illustrated Practical Guide
Redaktion: Dabaja, Bouthaina Shbib; Ng, Andrea K.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
¿Offers assistance in managing patients with difficult cases of the most common hematological malignancies
Presents a large number of illustrative cases covering typical scenarios
Explains treatment selection in detail, with the aid of high-quality images
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 14.48MB
Andere Kunden interessierten sich auch für
Ainaz SouratiAcute Side Effects of Radiation Therapy (eBook, PDF)72,95 €
Radiation Therapy Techniques and Treatment Planning for Breast Cancer (eBook, PDF)72,95 €
Target Volume Delineation and Treatment Planning for Particle Therapy (eBook, PDF)112,95 €
Handbook of Image-Guided Brachytherapy (eBook, PDF)112,95 €
Radiation Oncology for Pediatric CNS Tumors (eBook, PDF)88,95 €
Skin Care in Radiation Oncology (eBook, PDF)80,95 €
Gastrointestinal Malignancies (eBook, PDF)104,95 €-
-
-
¿Offers assistance in managing patients with difficult cases of the most common hematological malignancies
Presents a large number of illustrative cases covering typical scenarios
Explains treatment selection in detail, with the aid of high-quality images
Presents a large number of illustrative cases covering typical scenarios
Explains treatment selection in detail, with the aid of high-quality images
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer International Publishing
- Seitenzahl: 203
- Erscheinungstermin: 26. Oktober 2016
- Englisch
- ISBN-13: 9783319426150
- Artikelnr.: 46930674
- Verlag: Springer International Publishing
- Seitenzahl: 203
- Erscheinungstermin: 26. Oktober 2016
- Englisch
- ISBN-13: 9783319426150
- Artikelnr.: 46930674
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Bouthaina Dabaja is an Associate Professor in Radiation Oncology, Section chief of Hematologic Malignancies in the department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. Dr. Dabaja received her medical degree from the Lebanese University in Lebanon. She was trained in Internal Medicine and Medical Oncology at the American University of Beirut in Lebanon. Completed her training in Medical Oncology and Radiation Oncology at University of Texas MD Anderson Cancer Center. Dr. Dabaja is the Section chief of hematologic malignancies in the radiation oncology where she overseas the clinical and research activities and assist in the research development, specifically advancing the application of advanced technology in the treatment of both lymphoma and leukemia. Dr. Dabaja special interest, reflected by her publications in the field, is conducting research in an effort to reintroduce radiation into the treatment of hematologic malignancies with fewer side effects to maintain its long-term benefit. Andrea Ng is a Professor of Radiation Oncology at Harvard Medical School and Associate Clinical Director of Radiation Oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. Dr. Ng received her medical degree from Harvard Medical School, Boston, Massachusetts. She was trained in Radiation Oncology (Joint Center for Radiation Therapy, Boston, Massachusetts). Her research work focuses on analyses of treatment outcome as well as short- and long-term effects of radiation therapy in lymphoma patients, optimal follow-up of long-term survivors, and development of novel radiation therapy approaches to limit late effects of treatments while preserving its efficacy.
Part I: Hodgkin's Lymphoma: early stage favourable and unfavourable.- Advanced stage.- Primary refractory.- Relapsed Hodgkin's in the setting of transplant.- Part II: Non Hodgkin's Lymphoma: Diffuse Large Cell Lymphoma.- Early stage.- Advanced stage.- Refractory/palliative.- Follicular lymphoma: Early stage, grade 1,2.- Advanced stage/palliative.- Extranodal marginal zone: Gastrointestinal origin.- Non-gastrointestinal origin.- Primary mediastinal lymphoma.- Plasmacytoma/multiple myeloma.- Lymphoblastic lymphoma.- Primary CNS lymphoma.- Primary testicular lymphoma.- Mantle cell lymphoma.- Primary skin lymphoma including anaplastic large cell and mycosis fungoides.- Part III: Leukemia: craniospinal irradiation.- treatment of chloromas.
Part I: Hodgkin's Lymphoma: early stage favourable and unfavourable.- Advanced stage.- Primary refractory.- Relapsed Hodgkin's in the setting of transplant.- Part II: Non Hodgkin's Lymphoma: Diffuse Large Cell Lymphoma.- Early stage.- Advanced stage.- Refractory/palliative.- Follicular lymphoma: Early stage, grade 1,2.- Advanced stage/palliative.- Extranodal marginal zone: Gastrointestinal origin.- Non-gastrointestinal origin.- Primary mediastinal lymphoma.- Plasmacytoma/multiple myeloma.- Lymphoblastic lymphoma.- Primary CNS lymphoma.- Primary testicular lymphoma.- Mantle cell lymphoma.- Primary skin lymphoma including anaplastic large cell and mycosis fungoides.- Part III: Leukemia: craniospinal irradiation.- treatment of chloromas.







